Clinical Trial

A1Cantus vs. Placebo

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The investigators will conduct a randomized controlled 2-arm parallel trial of A1c Drink vs. Placebo over a 3-month period and compare changes in Ha1c from baseline to 3 months. Investigator and study personnel, as well as participants, will be blinded to drink assignments.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-07.
Trial Details
NCT Number NCT07585630
Lead Sponsor University of California, Riverside
Collaborators: A1Cantus
Conditions Type 2 Diabetes
Enrollment 50 participants
Start Date 2026-06-15
Primary Completion 2027-12-15 (estimated)
Study Completion 2028-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-18